alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Cowen Group, Inc. (the "Company") on Form 10-K/A for the year ended December 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to such officer's knowledge:


|   |                                                                                                                      
|-- | ---------------------------------------------------------------------------------------------------------------------
|1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

|   |                                                                                                                                                     
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------
|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




Date:March 30, 2015/s/ PETER A. COHENName:  Peter A. CohenTitle:    Chief Executive Officer             (principal executive officer)/s/ STEPHEN A. LASOTAName:  Stephen A. LasotaTitle:    Chief Financial Officer (principal financial             officer and principal accounting officer)





*  The foregoing certification is being furnished solely pursuant to 18 U.S.C Section 1350 and is not being filed as part of the Report or as a separate disclosure document
### TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-04-00167-CV

Office of Public Utility Counsel, Appellant

v. Public Utility Commission of Texas, Appellee

DIRECT APPEAL FROM THE PUBLIC UTILITY COMMISSION OF TEXAS

M E M O R A N D U M O P I N I O N
By order of May 6, 2004, this cause has been consolidated into, and will continue as, appeal number 03-04-00148-CV. No matters being left in cause 03-04-00167-CV, the appeal is dismissed.

W. Kenneth Law, Chief Justice Before Chief Justice Law, Justices Patterson and Puryear Appeal Dismissed Filed: May 6, 2004
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the quarterly report of StanCorp Financial Group, Inc. (the Company) on Form 10-Q for the quarter ended September 30, 2005, as filed
with the Securities and Exchange Commission on the date hereof (the Report), I, Eric E. Parsons, Chairman, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §
906 of the Sarbanes-Oxley Act of 2002, that:



(1) The Report fully complies
with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                                                               
|---------------------------------------------------------------
|Dated: November 8, 2005                                        
|                                                               
|/S/ ERIC E. PARSONS                                            
|Eric E. Parsons Chairman, President and Chief Executive Officer
#### Constance M. TUCKER, Petitioner, v. STATE of Florida, Respondent.

No. 44570.

Supreme Court of Florida.

Feb. 22, 1974.

CARLTON, C. J., and ADKINS, BOYD, McCAIN and DEKLE, JJ., concur.
Federal Depository Library ProgramPersistent URL Home Page      

# Target for /GPO/gpo20811 lost

The target resource for this PURL can no longer be traced. The following is a list of the targets this PURL was previously assigned to.

Powered by the Federal Depository Library Program.                A service of the U.S. Government Publishing Office.
[Federal Register Volume 62, Number 218 (Wednesday, November 12, 1997)]
[Rules and Regulations]
[Page 60657]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29649]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 558


New Animal Drugs for Use in Animal Feeds; Medicated Feed 
Applications; Lasalocid; Technical Amendment

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; technical amendment.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect the correct assay limits for lasalocid in 
Type A medicated articles. Although a supplement to the new animal drug 
application (NADA) was approved, the regulations had not been 
previously amended to reflect that approval. At this time the 
regulations are amended to reflect the current assay limits in the 
approved NADA.

EFFECTIVE DATE: November 12, 1997.

FOR FURTHER INFORMATION CONTACT: Mary G. Leadbetter, Center for 
Veterinary Medicine (HFV-143), Food and Drug Administration, 7500 
Standish Pl., Rockville, MD 20855, 301-594-1662.

SUPPLEMENTARY INFORMATION: FDA is amending the regulation concerning 
use of animal drugs in medicated feeds in Sec. 558.4(d) (21 CFR 
558.4(d)) to reflect that the assay limit for lasalocid Type A 
medicated articles is 95 to 115 percent of the labeled amount. Although 
the original approval for NADA 96-298 Hoffmann-LaRoche, Inc., provided 
for a 10 percent overage (an assay limit of 100 to 120 percent), a 
supplemental approval dated August 25, 1992, revised that overage to 5 
percent (95 to 115 percent). The regulation in Sec. 558.4(d) is amended 
in the table entitled ``Category I,'' in the entry for ``Lasalocid,'' 
accordingly.

List of Subjects in 21 CFR Part 558

    Animal drugs, Animal feeds.
    Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is 
amended as follows:

PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

    1. The authority citation for 21 CFR part 558 continues to read as 
follows:

    Authority: 21 U.S.C. 360b, 371.

Sec. 558.4  [Amended]

    2. Section 558.4 Medicated feed applications is amended in 
paragraph (d), in the table entitled ``Category I,'' in the entry for 
``Lasalocid,'' in the second column by removing ``100-120'' and adding 
in its place ``95-115''.

    Dated: October 21, 1997.
Robert C. Livingston,
Director, Office of New Animal Drug Evaluation, Center for Veterinary 
Medicine.
[FR Doc. 97-29649 Filed 11-10-97; 8:45 am]
BILLING CODE 4160-01-F
[Federal Register Volume 62, Number 215 (Thursday, November 6, 1997)]
[Notices]
[Page 60096]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29363]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Cancer Institute Special Emphasis Panel (SEP) meeting:

    Name of SEP: Phase III Science Enrichment Program (Telephone 
Conference Call).
    Date: November 17, 1997.
    Time: 8:00 a.m. to Adjournment.
    Place: National Cancer Institute, Executive Plaza North, 
Conference Room C, 6130 Executive Boulevard, Bethesda, MD 20892.
    Contact Person: Wilna Woods, Ph.D., Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 622B, 6130 Executive Boulevard, MSC 7405, Bethesda, MD 
20892-7405, Telephone: 301/496-7903.
    Purpose/Agenda: To review, discuss and evaluate responses to 
Request for Proposal.
    This notice is being published less than 15 days to the meeting 
due to the urgent need to meet timing limitations imposed by the 
review and funding cycle.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Proposals 
and the discussions could reveal confidential trade secrets or 
commercial property such as patentable material and personal 
information concerning individuals associated with the proposals, 
the disclosure of which would constitute a clearly unwarranted 
invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: October 30, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-29363 Filed 11-5-97; 8:45 am]
BILLING CODE 4140-01-M
USGS HomeContact USGSSearch USGS

Northern Prairie Wildlife Research Center

**Waterfowl Identification in the Central Flyway**

##       Lesser Scaup (Bluebill, Broadbill)    

----

**Male - Winter**
****

**Body:** Medium-sized duck, 1 3/4 - 2 pounds, 15-18 inches     long. Gray vermiculated back with white sides and belly. Head purple-black.     Chest and rump black. Eyes yellow. Bill light blue, short and broad. Feet     gray. **Wings:** Dark brown with white flecking on coverts and     tertials. Speculum white. **Voice:***Purr.***In     Flight:** Rapid wingbeat. Dark head and chest contrast with white belly.   

**Male - Fall**
****

 Ranging from bluish brown to blotchy near-winter coloration. Belly whitish.     Head dark with scattering of white at base of bill. Bill, eyes, feet and wings     same as in winter.   

**Female - All Seasons**
****

**Body:** Dull brown with distinct white belly. Prominent white     patch at base of bill. Eyes yellow. Bill and feet similar to male. **Wings:**     Dark brown with minute white flecking on coverts. Speculum white. **Voice:***Purr* or silent.   

****

----

Previous Section
Return to Contents
Next Section

AccessibilityFOIAPrivacyPolicies and Notices

U.S. Department of the Interior |		U.S. Geological Survey		URL: http://www.npwrc.usgs.gov/resource/birds/waterfwl/scaup.htm		Page Contact Information: Webmaster		Page Last Modified: Thursday, 03-Aug-2006 11:32:16 EDT		Sioux Falls, SD [sdww54]
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This  schedule  contains  summary  financial   information  extracted  from  the
registrant's  consolidated  financial  statements  for the twelve  months  ended
October 1, 2000 and is qualified in its entirety by reference to such  financial
statements.

</LEGEND>
<CIK>                         0000906473
<NAME>                        Starcraft Corporation
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              OCT-1-2000
<PERIOD-START>                                 OCT-3-1999
<PERIOD-END>                                   OCT-1-2000
<EXCHANGE-RATE>                                1.00
<CASH>                                         1,294
<SECURITIES>                                   0
<RECEIVABLES>                                  13,217
<ALLOWANCES>                                   255
<INVENTORY>                                    10,629
<CURRENT-ASSETS>                               26,038
<PP&E>                                         13,398
<DEPRECIATION>                                 5,752
<TOTAL-ASSETS>                                 34,944
<CURRENT-LIABILITIES>                          23,873
<BONDS>                                        9,957
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       14,382
<OTHER-SE>                                     (14,305)
<TOTAL-LIABILITY-AND-EQUITY>                   34,994
<SALES>                                        127,341
<TOTAL-REVENUES>                               127,341
<CGS>                                          110,045
<TOTAL-COSTS>                                  110,045
<OTHER-EXPENSES>                               14,922
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             1,447
<INCOME-PRETAX>                                (3,908)
<INCOME-TAX>                                   439
<INCOME-CONTINUING>                            (4,347)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (4,437)
<EPS-BASIC>                                    (1.03)
<EPS-DILUTED>                                  (1.03)



</TABLE>
United States Court of Appeals

FOR THE DISTRICT OF COLUMBIA CIRCUIT

____________

No. 22-5027 September Term, 2021

1:22-cv-00084-UNA

Filed On: March 22, 2022

Ido Zoldan, ID 039317904,

Appellant

v.

Government of the United States,

Appellee

ON APPEAL FROM THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF COLUMBIA

BEFORE: Tatel and Pillard, Circuit Judges, and Sentelle, Senior Circuit Judge

J U D G M E N T

This appeal was considered on the record from the United States District Court

for the District of Columbia and on the brief and supplement thereto filed by appellant. 

See Fed. R. App. P. 34(a)(2); D.C. Cir. Rule 34(j). Upon consideration of the foregoing,

it is

ORDERED AND ADJUDGED that the district court’s order filed January 24,

2022 be affirmed. The district court correctly determined that appellant lacked standing

to pursue the relief sought. See Lujan v. Defs. of Wildlife, 504 U.S. 555, 573-74 (1992)

(“[A] plaintiff raising only a generally available grievance about government . . . does not

state an Article III case or controversy.”). In addition, appellant has not plausibly

alleged any facts that show that appellee has waived its sovereign immunity. See FDIC

v. Meyer, 510 U.S. 471, 475 (1994) (“Sovereign immunity is jurisdictional in nature.”);

Bronner ex. rel. Am. Stud. Ass’n v. Duggan, 962 F.3d 596, 602 (D.C. Cir. 2020)

(“[O]nce jurisdiction is in question, ‘the party claiming subject matter jurisdiction . . . has

the burden to demonstrate that it exists.’”) (quoting Khadr v. United States, 529 F.3d

1112, 1115 (D.C. Cir. 2008)). 
United States Court of Appeals

FOR THE DISTRICT OF COLUMBIA CIRCUIT

____________

No. 22-5027 September Term, 2021

Pursuant to D.C. Circuit Rule 36, this disposition will not be published. The Clerk

is directed to withhold issuance of the mandate herein until seven days after resolution

of any timely petition for rehearing or petition for rehearing en banc. See Fed. R. App.

P. 41(b); D.C. Cir. Rule 41.

Per Curiam

FOR THE COURT:

Mark J. Langer, Clerk 

BY: /s/

Daniel J. Reidy 

Deputy Clerk

Page 2
-80 -79 -78 -77 -76
38 39 40 

### ★

▲ ▲ ▲ ▲


### ★ ▲ ▲ ▲ ▲ 500 1000 1500 500 18 12 06 00 06/28 

### NOAA HYSPLIT MODEL 

## Backward trajectory ending at 2300 UTC 28 Jun 06

EDAS Meteorological DataSource★at 38.90 N 76.65 WMeters AGL
#### LAWRENCE WAREHOUSE COMPANY, a California corporation, and Norman Bruce, Petitioners, v. INTERNATIONAL ERECTORS, INC., Respondent.

No. 2470.

District Court of Appeal of Florida. Fourth District.

May 12, 1969.

PER CURIAM.

Certiorari denied.
[Federal Register Volume 62, Number 216 (Friday, November 7, 1997)]
[Notices]
[Pages 60250-60251]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29409]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Closed 
Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Child Health and Human Development Special 
Emphasis Panel (SEP) meeting:

    Name of Sep: Initiation of Human Labor: Prevention of 
Prematurity.
    Date: November 6-7, 1997.
    Time: November 6--7:30 p.m.-10 p.m.; November 7--8:30 a.m.--
adjournment.
    Place: University of South West Medical Center/Dallas, 5323 
Harry Hines Boulevard, Dallas, Texas 75235.
    Contact Person: Gopal M. Bhatnagar, Ph.D., Scientific Review 
Administrator, NICHD, 6100 Executive Boulevard, Room 5E01, 
Rockville, MD 20852, Telephone: 301-496-1485.
    Purpose/Agenda: To evaluate and review a research grant 
application.
    This meeting will be closed in accordance with the provisions 
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The 
discussion of this application could reveal confidential trade 
secrets or commercial property such as patentable material and 
personal information concerning individuals associated with the 
application, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

[[Page 60251]]

(Catalog of Federal Domestic Assistance Program Nos. [93.864, 
Population Research and No. 93.865, Research for Mothers and 
Children], National Institute of Health, HHS)

    Dated: October 31, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, National Institutes of Health.
[FR Doc. 97-29409 Filed 11-6-97; 8:45 am]
BILLING CODE 4140-01-M
ASSIGNMENT AND ASSUMPTION AGREEMENT 

This Assignment and Assumption Agreement (the "Assignment and Assumption Agreement") is entered into as of 

12/05/2013 by and between ;;B;;•:.::n:::k~o:.::..f:..:A:::m:.:e::..:ri::::ca::L.:.N;.:.A!.:;!... ----------------~---­

("Assignor") and Ameriana Bank, SB ("Assignee"). 

All terms used, but not defined, herein shall have the meanings ascribed to them in the Underlying Agreement (defined 

below). 

WHEREAS, Assignor and Federal National Mortgage Association, a federally chartered corporation, as financial agent of 

the United States ("Fannie Mae"), are parties to a Commitment to Purchase Financial Instrument and Servicer 

Participation Agreement, a complete copy of which (including all exhibits, amendments and modifications thereto) is 

attached hereto and incorporated herein by this reference (the "Underlying Agreement"); 

WHEREAS, Assignor has agreed to assign to Assignee all of its rights and obligations under the Underlying Agreement 

with respect to the Eligible Loans that are identified on the schedule attached hereto as Schedule 1 (collectively, the 

"Assigned Rights and Obligations"); and 

WHEREAS, Assignee has agreed to assume the Assigned Rights and Obligations. 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby 

acknowledged, the parties hereto agree as follows: 

1. Assignment. Assignor hereby assigns to Assignee all of Assignor's rights and obligations under the Underlying 

Agreement with respect to the Assigned Rights and Obligations. 

2. Assumption. Assignee hereby accepts the foregoing assignment and assumes all of the rights and obligations of 

Assignor under the Underlying Agreement with respect to the Assigned Rights and Obligations. 

3. Effective Date. The date on which the assignment and assumption of rights and obligations under the Underlying 

Agreement is effective is -=1.:..;:/0:..:t.:..;:/2:..:0..:.14.;__ ______ _ 

4. Successors. All future transfers and assignments of the Assigned Rights and Obligations transferred and assigned 

hereby are subject to the transfer and assignment provisions of the Underlying Agreement. This Assignment and 

Assumption Agreement shall inure to the benefit of, and be binding upon, the permitted successors and assigns of the 

parties hereto. 

5. Counterparts. This Assignment and Assumption Agreement may be executed in counterparts, each of which shall be 

an original, but all of which together constitute one and the same instrument. 

E-1 
IN WITNESS WHEREOF, Assignor and Assignee, by their duly authorized officials, hereby execute and deliver this 

Assignment and Assumption Agreement, together with Schedule 1, effective as of the date set forth in Section 3 above. 

ASSIGNOR: Bank of America, N.A. ASSIGNEE: Amcriana Bank, SB 

Title: SVP 

Date: ~a CJ:>i I 1 

Name~ A~~ Title: SVP/modgo.ge= ·lfj' 

Date: /;L · 17 ·10
[Federal Register Volume 62, Number 216 (Friday, November 7, 1997)]
[Notices]
[Page 60282]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29455]


-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Employment and Training Administration
[NAFTA-01223]


Johnson & Johnson Medical, Incorporated Including Temporary 
Workers of Kelly Services, Incorporated El Paso, Texas; Amended 
Certification Regarding Eligibility To Apply for NAFTA-Transitional 
Adjustment Assistance

    In accordance with Section 250(A), Subchapter D, Chapter 2, Title 
II, of the Trade Act of 1974 (19 USC 2273), the Department of Labor 
issued a Certification for NAFTA Transitional Adjustment Assistance on 
October 9, 1996, applicable to all workers of Johnson & Johnson 
Medical, Incorporated, located in El Paso, Texas. The notice will be 
published soon in the Federal Register.
    At the request of the State agency, the Department reviewed the 
certification for workers of the subject firm. New information provided 
by the State shows that some workers of Johnson & Johnson Medical, 
Incorporated were temporary workers of Kelly Services, Incorporated 
employed to produce surgical gowns, drapes and sheets at the El Paso, 
Texas facility. Based on these findings, the Department is amending the 
certification to include temporary workers from Kelly Services, 
Incorporated, El Paso, Texas who were engaged in the production of 
surgical gowns, drapes and sheets at Johnson and Johnson Medical, 
Incorporated, El Paso, Texas.
    The intent of the Department's certification is to include all 
workers of Johnson & Johnson Medical, Incorporated adversely affected 
by the shift of production to Mexico. Accordingly, the Department is 
amending the certification to reflect this matter.
    The amended notice applicable to NAFTA--01223 is hereby issued as 
follows:

    All workers of Johnson & Johnson Medical, Incorporated, El Paso, 
Texas and temporary workers of Kelly Services, El Paso, Texas, 
engaged in employment related to the production of surgical gowns, 
drapes and sheets for Johnson & Johnson Medical, Incorporated, El 
Paso, Texas who became totally or partially separated from 
employment on or after August 29, 1995 are eligible to apply for 
NAFTA-TAA under Section 250 of the Trade Act of 1974.

    Signed at Washington, D.C. this 30th day of October, 1997.
Grant D. Beale,
Acting Director, Office of Trade Adjustment Assistance.
[FR Doc. 97-29455 Filed 11-6-97; 8:45 am]
BILLING CODE 4510-30-M